Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Acutus Medical's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-10.30 Mil. Acutus Medical's Total Assets for the quarter that ended in Sep. 2024 was $32.17 Mil.
Therefore, Acutus Medical's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was -0.32.
The historical rank and industry rank for Acutus Medical's Equity-to-Asset or its related term are showing as below:
AFIB'
s Equity-to-Asset Range Over the Past 10 Years
Min: -5.08 Med: 0.5 Max: 0.72
Current: -0.32
During the past 6 years, the highest Equity to Asset Ratio of Acutus Medical was 0.72. The lowest was -5.08. And the median was 0.50.
AFIB's Equity-to-Asset is ranked worse than 93.43% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs AFIB: -0.32
Acutus Medical Equity-to-Asset Historical Data
The historical data trend for Acutus Medical's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acutus Medical's Equity-to-Asset
For the Medical Devices subindustry, Acutus Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutus Medical's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acutus Medical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Acutus Medical's Equity-to-Asset falls into.
Acutus Medical Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Acutus Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutus Medical (OTCPK:AFIB) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Acutus Medical Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Acutus Medical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AFIB has been successfully added to your 